Tom Kent Joins Maverix as Vice President of R&D

News   Mar 12, 2015

 
Tom Kent Joins Maverix as Vice President of R&D
 
 
 

RELATED ARTICLES

Existing 20-year-old Multiple Sclerosis Drug Effective Against Multi-resistant Bacteria

News

A widely-used and twenty-year-old medicine used to treat multiple sclerosis can also beat a type of multi-resistant bacteria for which there are currently only a few effective drugs.

READ MORE

Revolutionary Imaging Technique Uses CRISPR to Map DNA Mutations

News

The new high-speed AFM method can map DNA to a resolution of tens of base pairs while creating images up to a million base pairs in size. And it does it using a fraction of the amount of specimen required for DNA sequencing.

READ MORE

Novel Approach May Aid Rare Liver Cancer Patients

News

After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE